The Gross Law Firm issues the following notice to shareholders of Rentokil Initial plc (NYSE: RTO). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of RTO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Rentokil […]

The Gross Law Firm issues the following notice to shareholders ofMatch Group, Inc. (NASDAQ: MTCH). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MTCH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Match Group,

The Gross Law Firm issues the following notice to shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of KSPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:

The Gross Law Firm issues the following notice to shareholders ofWarner Bros. Discovery, Inc. (NASDAQ: WBD). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of WBD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Warner

SINGAPORE, Jan. 23, 2025 (GLOBE NEWSWIRE) — Mediway Medical Centre is pleased to announce two significant achievements: the centre has surpassed 5,000 reviews on Google with an impressive 4.9-star rating, and it is launching a comprehensive Allergy Test Panel featuring 83 different allergens. The positive feedback from patients underscores the centre's commitment to providing exceptional

(NasdaqGM:ENPH), SAN DIEGO, Jan. 23, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enphase Energy, Inc. (NASDAQ: ENPH) common stock between April 25, 2023 and October 22, 2024, both dates inclusive (the “Class Period”), have until Tuesday, February 11, 2025 to seek appointment as lead plaintiff of

Hours after the inauguration of Donald J. Trump, his administration deleted reproductiverights.gov, a government website providing information on abortion access. While this action is considered a victory by the life-affirming movement, there is still much work ahead to become a nation that fully values life. To continue this work, Save the Storks is kicking off

The first FcRn blocker to demonstrate sustained disease control over 24 weeks in antibody positive adult patients: anti-AChR+, anti-MuSK+, anti-LRP4+ Nipocalimab demonstrated a sustained reduction in autoantibody levels, one of the underlying causes of gMG, by up to 75% over a period of 24 weeks The investigational therapy was recently granted U.S. FDA Priority Review

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=124540&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical and transdermal pharmaceutical research and development company, with proprietary Invisicare® drug delivery technology, today announces significant achievements in 2024 and 2025, through its licensee Quoin Pharmaceuticals’ progress in Netherton Syndrome treatment. Skinvisible granted